VERTEX PHARMACEUTICALS INC / MA Marketable Securities, Current in USD from Q4 2017 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
Vertex Pharmaceuticals Inc / Ma quarterly Marketable Securities, Current history and growth rate from Q4 2017 to Q3 2025.
  • Vertex Pharmaceuticals Inc / Ma Marketable Securities, Current for the quarter ending September 30, 2025 was $1.35B, a 4.83% increase year-over-year.
Marketable Securities, Current, Quarterly (USD)
Marketable Securities, Current, YoY Quarterly Growth (%)

VERTEX PHARMACEUTICALS INC / MA Quarterly Marketable Securities, Current (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $1.35B +$62.1M +4.83% Sep 30, 2025 10-Q 2025-11-04
Q2 2025 $1.41B +$195M +16.1% Jun 30, 2025 10-Q 2025-08-05
Q1 2025 $1.53B +$513M +50.6% Mar 31, 2025 10-Q 2025-05-06
Q4 2024 $1.55B +$697M +82.1% Dec 31, 2024 10-Q 2025-11-04
Q3 2024 $1.29B +$467M +57.1% Sep 30, 2024 10-Q 2024-11-05
Q2 2024 $1.22B +$130M +12% Jun 30, 2024 10-Q 2024-08-02
Q1 2024 $1.01B -$111M -9.87% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $849M +$575M +209% Dec 31, 2023 10-K 2025-02-13
Q3 2023 $818M +$219M +36.5% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $1.09B +$534M +96.9% Jun 30, 2023 10-Q 2023-08-02
Q1 2023 $1.12B +$486M +76.2% Mar 31, 2023 10-Q 2023-05-02
Q4 2022 $275M -$455M -62.4% Dec 31, 2022 10-K 2024-02-15
Q3 2022 $599M -$86M -12.5% Sep 30, 2022 10-Q 2022-10-28
Q2 2022 $551M -$93.1M -14.5% Jun 30, 2022 10-Q 2022-08-05
Q1 2022 $638M +$18.4M +2.96% Mar 31, 2022 10-Q 2022-05-06
Q4 2021 $730M +$59.2M +8.83% Dec 31, 2021 10-K 2023-02-10
Q3 2021 $685M -$108M -13.6% Sep 30, 2021 10-Q 2021-11-03
Q2 2021 $644M +$24.9M +4.02% Jun 30, 2021 10-Q 2021-07-30
Q1 2021 $620M +$22.7M +3.8% Mar 31, 2021 10-Q 2021-04-30
Q4 2020 $671M -$28.3M -4.05% Dec 31, 2020 10-K 2022-02-09
Q3 2020 $793M +$195M +32.5% Sep 30, 2020 10-Q 2020-10-30
Q2 2020 $619M -$37.1M -5.65% Jun 30, 2020 10-Q 2020-07-31
Q1 2020 $597M +$12.8M +2.2% Mar 31, 2020 10-Q 2020-05-01
Q4 2019 $699M +$181M +34.9% Dec 31, 2019 10-K 2021-02-11
Q3 2019 $598M +$20.8M +3.6% Sep 30, 2019 10-Q 2019-10-31
Q2 2019 $657M +$34.1M +5.49% Jun 30, 2019 10-Q 2019-08-01
Q1 2019 $584M +$103M +21.4% Mar 31, 2019 10-Q 2019-05-01
Q4 2018 $518M +$94.9M +22.4% Dec 31, 2018 10-K 2020-02-13
Q3 2018 $578M Sep 30, 2018 10-Q 2018-10-25
Q2 2018 $622M Jun 30, 2018 10-Q 2018-07-26
Q1 2018 $481M Mar 31, 2018 10-Q 2018-04-27
Q4 2017 $423M Dec 31, 2017 10-Q 2018-10-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.